J. Goldman & Co’s Otonomy, Inc. OTIC Stock Holding History

J. Goldman & Co’s Portfolio OTIC Stock Details OTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-225,000	Closed	-$468K	–	529
2022 Q2	$468K	Buy	+225,000	New	+$468K	0.02%	284

Other funds holding OTIC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

J. Goldman & Co's OTIC Position: Q3 2022 in Review

J. Goldman & Co sold out of Otonomy, Inc. (OTIC) in Q3 2022, closing a stake of 135,000 shares — an estimated $281K sold.

J. Goldman & Co first reported a position in OTIC in Q4 2017 and held it in 9 quarters. The position peaked at $3.75M in Q3 2020. 40 funds tracked by Wall St. Rank hold OTIC as of Q3 2022.

J. Goldman & Co reported no remaining Otonomy, Inc. position as of Q3 2022 after selling out during the quarter.
J. Goldman & Co sold 135,000 Otonomy, Inc. shares in Q3 2022, an estimated $281K.
J. Goldman & Co first reported a position in Otonomy, Inc. in Q4 2017 and held it in 9 quarters.
J. Goldman & Co's Otonomy, Inc. position peaked at $3.75M in Q3 2020.
40 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q3 2022.

Based on J. Goldman & Co's 13F filing for Q3 2022, filed 14 Nov 2022.